Studies have shown that the dysregulation of UCA1 is closely associated with the clinicopathological characteristics of cancer, such as lymph node metastasis (LNM) and overall survival (OS). This evidence concerns the gene UCA1 and metastatic malignant neoplasm in the lymph nodes.